Codes / ICD10CM / T38.2X5A

T38.2X5A Adverse effect of antithyroid drugs, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of antithyroid drugs, initial encounter

Summary

This condition represents an adverse reaction to antithyroid drugs during the initial encounter. Antithyroid agents are used to treat hyperthyroidism by reducing thyroid hormone production, and this code applies when the adverse effect is newly identified and documented as part of the initial clinical presentation.

Causes

The cause is an adverse reaction to antithyroid medications, such as methimazole or propylthiouracil, that occurs during their use. This may result from individual sensitivity, drug interactions, or unexpected responses to therapeutic dosing, even when the medication is prescribed appropriately.

Risk Factors

  • Use of antithyroid drug therapies for hyperthyroidism
  • Polypharmacy involving antithyroid agents
  • Individual sensitivity to antithyroid substances
  • Renal or hepatic impairment affecting drug metabolism
  • Concurrent use of other medications that interact with antithyroid drugs

Symptoms

Symptoms vary based on the specific agent and reaction type: common effects include hypothyroidism (e.g., fatigue, weight gain, cold intolerance) or allergic reactions (e.g., rash, itching). Severe reactions may involve organ-specific toxicity, such as hepatotoxicity or agranulocytosis, which can present with jaundice or fever.

Diagnosis

Diagnosis relies on a thorough medication history, clinical evaluation of symptoms, and lab tests to assess thyroid function and rule out other causes. Documentation must confirm the adverse effect is related to antithyroid drug use and is part of the initial encounter.

Treatment Options

Treatment focuses on discontinuing the offending drug, managing symptoms, and providing supportive care. For mild reactions, observation and symptom relief may suffice. Severe cases may require hospitalization, specific antidotes (if available), or alternative therapies for hyperthyroidism.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most mild adverse effects resolve with drug discontinuation, but severe reactions may have lasting impacts. Follow-up includes monitoring thyroid function and assessing for recurrence or new symptoms.

Complications

Complications can include prolonged hypothyroidism, organ damage (e.g., liver or bone marrow), or treatment delays for underlying hyperthyroidism. Severe reactions may require long-term management or alternative therapies.

Lifestyle & Prevention

Prevention involves careful medication review, patient education on proper use, and monitoring for early signs of adverse effects. Avoiding drug interactions and adjusting doses for renal/hepatic impairment can reduce risk.

When to Seek Professional Help

Seek immediate care for severe symptoms like jaundice, high fever, or difficulty breathing. Contact a healthcare provider for persistent or worsening symptoms, such as unexplained fatigue, weight changes, or skin reactions, after starting antithyroid therapy.

Tips for Medical Coders

Document the initial encounter and confirm the adverse effect is directly related to antithyroid drug use. Ensure the code is not used for underdosing, poisoning, or intentional self-harm scenarios. Verify that the encounter is the first time the adverse effect is identified and treated.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T38.2X5A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.